Camberlogo (Camberlogo)
Theophylline Tablet, Extended Release
Product Images NDC 31722-077
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 31722-077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Theophylline300mglabel (Theophylline300mglabel)
Not available*
Theophylline450mglabel (Theophylline450mglabel)
This is a description for Theophylline Extended-Release Tablets. Each tablet contains 300mg of Theophylline (Anhydrous) USP. The usual dosage can be found in the package insert. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). They should be dispensed in a well-closed container with a child-resistant closure as defined in the USP. The contact number for the United States is 1-866-495-1995. The tablets are manufactured by Camber Pharmaceuticals, Inc., located in Piscataway, NJ 08854. The manufacturing license number is 24/MD/TS/20161F/6. The document also includes some unrelated text about an area measurement and a pharmaceutical company located in Sangareddy, India.*
Theophyllineertabletsstructure (Theophyllineertabletsstructure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
